arrow
E

Eva Ellebæk

Copenhagen University Hospital - Herlev and Gentofte
H指数:24
被引数:2,823

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Early discontinuation of immune checkpoint inhibitors after objective response in real-world melanoma: clinical and economic impact

黑色素瘤真实世界中客观缓解后免疫检查点抑制剂的早期停药:临床和经济影响

2026-10-220
OA
Dabrafenib plus trametinib vs encorafenib plus binimetinib in BRAF-mutant metastatic melanoma: a real-world propensity score-matched survival analysis

达拉非尼联合曲美替尼与恩考拉非尼联合比美替尼在BRAF突变型转移性黑色素瘤中的比较:一项真实世界倾向性评分匹配的生存分析

2025-10-010
PRE
Long-term clinical outcome of patients with metastatic melanoma and initial stable disease during anti-PD-1 checkpoint inhibitor immunotherapy with pembrolizumab

接受帕博利珠单抗抗PD-1检查点抑制剂免疫治疗的转移性黑色素瘤患者,且初始病情稳定的长期临床结局

2025-05-260
OA
18F-FDG PET/CT assessment of metabolic tumor burden predicts survival in patients with metastatic posterior uveal melanoma

18F-FDG PET/CT评估代谢性肿瘤负荷可预测转移性后葡萄膜黑色素瘤患者的生存

2025-02-030
OAAI
Immune-related adverse events in a nationwide cohort of real-world melanoma patients treated with adjuvant anti-PD1-Seasonal variation and association with outcome

在全国范围内接受辅助anti-PD1-Seasonal变异治疗的真实世界黑色素瘤患者队列中与免疫相关的不良事件及其与结果的关联

2024-11-010
OAAI
A prospective study of patients with immune checkpoint inhibitor-induced hepatitis: Management outcome and association with liver injury subtype, immune infiltration, and clinical parameters

一项关于免疫检查点抑制剂诱导性肝炎患者的回顾性研究:管理结局及其与肝脏损伤亚型、免疫浸润和临床参数的关联

2024-09-010
PRE